Overview
Ajay Vishwakarma is Founder and CEO of Cell BioEngines, Inc., where Vishwakarma leads development of scalable allogeneic cell therapies for cancer, immune-related diseases and regenerative medicine [2]. Vishwakarma holds a DMD, MS, and MBA, with training at Harvard Medical School, MIT, and the Broad Institute [2]. Vishwakarma's background includes work as an Associate Researcher at the Broad Institute of MIT and Harvard from November 2017 to June 2020 [7], and as a Post-doctoral Fellow in Immune Engineering at Harvard University from December 2013 to July 2015 [11]. Vishwakarma is also Founder at Endless Frontier Labs [1][4].
Profile introduction
Ajay Vishwakarma, DMD, MS, MBA is the Founder and CEO of Cell BioEngines, Inc., where he leads the development of scalable allogeneic cell therapies for cancer, immune-related diseases and regenerative medicine. Trained at Harvard Medical School, MIT, and the Broad Institute, he combines deep expertise in cancer immunology, biomaterials and stem cell biology with venture-backed company-building experience.
Career history
- Founder and CEODec 2022 to presentCell BioEngines, Inc
- Founder at Endless Frontier LabsSep 2025 to presentEndless Frontier Labs
- Account Manager, Cell AnalysisJul 2022 to Dec 2022Agilent Technologies
- MBA in FinanceSep 2020 to Aug 2022University of Massachusetts
- Associate ResearcherNov 2017 to Jun 2020Broad Institute of MIT and Harvard
- PhD StudentSep 2017 to Jun 2020Massachusetts General Hospital
Education
PhD Student (ABD), Harvard Program in Therapeutic ScienceSep 2017 - Jun 2020Harvard University
- PhD Candidate, Oncology and Cancer BiologySep 2015 - Aug 2017University of Iowa Roy J. and Lucille A. Carver College of Medicine
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.